PDS Biotechnology

Frank Bedu-Addo, Ph.D., CEO & Director of PDS Biotechnology (NASDAQ: PDSB), was recently a guest on Benzinga’s All-Access. PDS Biotech is a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines. The company’s...